Inventor
Dale P. Spangler
Inventor
Deerfield, IL, US
Overview
Patents· 48 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds27%
C07CAcyclic or carbocyclic compounds20%
C07BGeneral methods of organic chemistry19%
B01DSeparation14%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations13%
A61KPreparations for medical, dental or toiletry purposes7%
PatentTitleYear
7,700,658'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity'20107,253,211'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity'20077,122,536'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity'20067,119,098'Heteroarylakanoic acids as intergrin receptor antagonists'20067,115,596'Thiazole compounds as integrin receptor antagonists derivatives'20066,933,304'Heteroarylalkanoic acids as integrin receptor antagonists'20056,803,388'(R)-Chiral halogenated substituted n,n-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,765,023'Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,723,752'(R)-chiral halogenated substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,723,753'Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,710,089'Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,699,898'Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,696,472'Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,696,435'Substituted N,N-disubstituted fused-heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,683,099'Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,683,113'(R)-chiral halogenated substituted N,N-Bis-benzyl aminioalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,380'Substituted N, N-disubstituted mercapto amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,379'Substituted N,N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,382'Substituted N,N-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,341'(R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,375'Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,677,353'Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20046,586,433'Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,583,183'Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,544,974'(R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,521,607'(R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity'20036,479,552'Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity'20026,476,075'Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity'20026,476,057'Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,462,092'Use of substituted N, N-disubstituted reverse aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,458,849'use of substituted N,N-disubstituted mercapto amino compounds for inhibiting cholesteryl ester transfer protein activity'20026,458,803'Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,458,852'Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,455,519'Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity'20026,451,823'Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,451,830'Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity'20026,448,295'Use of substituted N-fused-phenyl-N-benzyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity'20026,448,286'Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors'20026,344,483'Halogenated amidino amino acid deviratives useful as nitric oxide synthase inhibitors'20026,071,906'Imidino piperidine derivatives useful as nitric oxide synthase inhibitors'20006,046,211'Amidino derivatives useful as nitric oxide synthase inhibitors'20006,043,261'Pyrrolodino imidines useful as nitric oxide synthase inhibitors'20006,011,028'Cyclic amidino agents useful as nitric oxide synthase inhibitors'20005,883,251'Azepine derivatives useful as nitric oxide synthase inhibitors'19995,854,234'Amidino dervatives useful as nitric oxide synthase inhibitors'1998RE035218'Azatetracycle compounds'19965,223,613'Azatetracycle compounds and process of preparing same'19935,140,023'Azatetracycle compounds'1992Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1992–2003Patents assigned to SEARLE & CO (23)· patent assignee history
1992–2010Based in Deerfield, IL, US· patent location history
2003–2006Patents assigned to PHARMACIA CORP (19)· patent assignee history
2004–2010Patents assigned to PFIZER (5)· patent assignee history
2004Patents assigned to PHARMACIA CORP GLOBAL PATENT D (1)· patent assignee history
2006Based in San Diego, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SEARLE & CO | 23 | 1992–2003 |
| PHARMACIA CORP | 19 | 2003–2006 |
| PFIZER | 5 | 2004–2010 |
| PHARMACIA CORP GLOBAL PATENT D | 1 | 2004 |
Locations
| Location | Patents | Span |
|---|---|---|
| Deerfield, Illinois, US | 47 | 1992–2010 |
| San Diego, California, US | 1 | 2006 |